`
`
`Haller, et al.
`In re Patent of:
`7,039,033 Attorney Docket No.: 39521-0020IP3
`U.S. Patent No.:
`May 2, 2006
`
`Issue Date:
`Appl. Serial No.: 09/850,399
`
`Filing Date:
`May 7, 2001
`
`Title:
`System, device and computer readable medium for providing
`a managed wireless network using short-range radio signals
`
`
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`PETITIONER’S MOTION FOR JOINDER AND/OR CONSOLIDATION
`
`
`
`
`
`
`
`1
`
`
`
`
`
`Attorney Docket No. 39521-0020IP3
`Proceeding No. IPR2019-00139
`
`STATEMENT OF RELIEF REQUESTED
`
`Pursuant to 35 U.S.C. § 315(d) and 37 C.F.R. §§ 41.122(a), Petitioner Apple
`
`Inc. (“Apple”) files this motion asking the Board to consolidate the present IPR with
`
`Case No. IPR2015-01444, which addresses the patentability of claims of U.S. Patent
`
`7,039,033 (“the ’033 patent”) over prior art references also relied on in this petition.
`
`INTRODUCTION
`
`Apple originally filed a petition seeking inter partes review of claims 1, 4-7,
`
`12, 14, 15, 22, 23, 25, 28, 34, 39, 40, 42, and 46 of the ’033 patent on June 19, 2015.
`
`Apple’s first petition was filed well before the statutory bar deadline: IXI initiated
`
`suit against Apple in October of 2014, and Apple’s petition was filed eight months
`
`later. See id. at 3; see also IXI Mobile (R&D) and IXI IP, LLC v. Apple Inc., Case
`
`4:15-cv-03755, D.I. 1 (N.D. Cal. October 2, 2014). Notably, Apple’s petition sought
`
`review of every claim that IXI had asserted against it in litigation. The Board
`
`instituted as to every claim challenged (IPR2015-01444, Paper 8), and after briefing
`
`and a hearing, cancelled every challenged claim as being unpatentable over PCT
`
`Publication No. WO 01/76154 A2 to Marchand (“Marchand”) in combination with
`
`various other references (id., Paper 27). IXI appealed the Board’s decision,
`
`contending it was not supported by substantial evidence. See IXI IP, LLC v. Samsung
`
`Elecs. Co. et al., Case No. 17-1665, D.I. 16 (Fed. Cir. June 2, 2017). The Federal
`
`2
`
`
`
`
`Circuit affirmed on September 10, 2018, and issued its mandate giving jurisdiction
`
`Attorney Docket No. 39521-0020IP3
`Proceeding No. IPR2019-00139
`
`back to the Board on October 17, 2018.
`
`On March 24, 2017—after the § 315(b) bar date and after this Board found all
`
`challenged claims unpatentable in the previous IPR—Patent Owner IXI IP, LLC
`
`(“IXI”) requested reexamination of the ’033 patent to amend the claims in light of
`
`substantial new questions of patentability raised by the prior art cited by Apple in
`
`the IPR. A reexamination certificate issued on February 1, 2018, which cancelled a
`
`number of claims not asserted in the litigation or challenged in the prior IPR, but
`
`amended independent claim 56 and added claims 57–124. As explained in Apple’s
`
`petition, these amendments simply took subject matter already found to be
`
`unpatentable in the IPR proceeding and added well-known functionality of mobile
`
`devices.
`
`Thus, Apple filed the instant petition to challenge the patentability of the new
`
`claims added during IXI’s reexamination. Apple respectfully requests joinder of this
`
`IPR with its previously-filed IPR (Case No. IPR2015-01444). As will be explained
`
`below, joinder is appropriate to secure a just, speedy, and inexpensive resolution of
`
`the dispute as to the patentability of the new claims, and is warranted because of the
`
`substantial overlap in the issues and art involved in both proceedings. See Gea
`
`Process Engr., Inc. Petr., IPR2014-00051, 2014 WL 1253170, at *6 (Patent Tr. &
`
`App. Bd. Mar. 10, 2014) (allowing consideration of claims amended in ex parte
`
`3
`
`
`
`
`reexamination because “our consideration of the amended claims in the
`
`Attorney Docket No. 39521-0020IP3
`Proceeding No. IPR2019-00139
`
`reexamination certificate at this time advances our obligation to secure the ‘just,
`
`speedy, and inexpensive resolution’ of every proceeding”); Microsoft Corp. v.
`
`Proxyconn, Inc., IPR2013-00109, Paper 15 (PTAB Feb. 25, 2013) (allowing joinder
`
`because of commonality of issues between two IPRs). Moreover, the minimal
`
`amount of work required on the part of the Patent Owner to address the new claims
`
`(work which, for the most part, should have already been done during the
`
`reexamination and prior IPR) is far outweighed by the public interest in having
`
`consistency of outcome concerning similar sets of claimed subject matter and prior
`
`art. See Amneal Pharm. LLC. v. Endo Pharm. Inc., IPR2014-01365, Paper 13
`
`(PTAB Feb. 4, 2015); Samsung Elecs. Co., Ltd. v. Virginia Innovation Scis., Inc.,
`
`IPR2014-00557, Paper 10 at 18 (PTAB June 13, 2014).
`
`LEGAL PRINCIPLES
`
`
`
`Section 315(d) of the Patent Act gives the PTO broad discretion to organize
`
`proceedings before it in any manner it sees fit. Specifically, where there are multiple
`
`proceedings involving the same patent before the Office, this section allows the
`
`director (or his assigns, such as the Board) to determine “the manner in which the
`
`inter partes review or other proceeding or matter may proceed, including providing
`
`for stay, transfer, consolidation, or termination of any such matter or proceeding.”
`
`35 U.S.C. § 315(d); see also 157 Cong. Rec. S 9988 (daily ed. Sept. 27, 2008)
`
`4
`
`
`
`
`(statement of Sen. Kyl) (explaining that the analogous “Section 325(c) gives the PTO
`
`Attorney Docket No. 39521-0020IP3
`Proceeding No. IPR2019-00139
`
`broad discretion to consolidate, stay, or terminate any PTO proceeding involving a
`
`patent if that patent is the subject of a postgrant review proceeding.”). Notably,
`
`unlike the provision governing joinder of parties (§ 315(c)), this section does not
`
`provide for any time limit on when a party may request consolidation or for when
`
`the Board may consolidate proceedings.
`
`
`
`The PTO has recognized this broad authority in its regulations. In
`
`implementing § 315(d), the Board promulgated a regulation providing that “the
`
`Board may during the pendency of the inter partes review enter any appropriate order
`
`regarding the additional matter including providing for the stay, transfer,
`
`consolidation, or termination of any such matter.” 37 C.F.R. § 42.122(a). Notably,
`
`although the Board has set forth specific time periods for joinder of parties, again no
`
`time limit is set for a consolidation of different proceedings. In addition, the PTO
`
`has given the Board broad authority to “determine a proper course of conduct in a
`
`proceeding for any situation not specifically covered by this part and may enter non-
`
`final orders to administer the proceeding.” 37 C.F.R. § 42.5.
`
`
`
`Although this request is made specifically pursuant to section 315(d) of the
`
`Patent Act and not section 315(c), the Board has made clear that the principles
`
`discussed in relation to section 315(c) are applicable to both requests for joinder of
`
`parties and joinder of issues. See Medtronic, IPR2014-00823, 2014 WL 6985725,
`
`5
`
`
`
`
`at *5 (“we conclude that § 315(c) encompasses both party joinder and issue joinder,
`
`Attorney Docket No. 39521-0020IP3
`Proceeding No. IPR2019-00139
`
`and as such, permits the joinder of any person who properly files a petition under §
`
`311, including a petitioner who is already a party to the existing inter partes
`
`review.”). Thus, as laid out in section 315(c), and as recognized by the Board, a
`
`petition will not be barred by § 315(b) if it is joined to a proceeding resulting from a
`
`timely-filed petition. See 37 C.F.R. § 42.122 (“The time period set forth in §
`
`42.101(b) shall not apply when the petition is accompanied by a request for
`
`joinder.”). Moreover, as laid out by the Board in Kyocera Corp. v. Softview, LLC,
`
`IPR2013-00004, Paper 15 at 4 (PTAB April 24, 2013), motions seeking
`
`consolidation or joinder should (1) provide the reasons why joinder is appropriate;
`
`(2) identify any new grounds of unpatentability being raised in the subsequent
`
`petition; (3) explain what impact (if any) there will be on the trial schedule for the
`
`existing review; and (4) address how briefing and/or discovery may be simplified to
`
`minimize schedule impact. Id.; see also Samsung Elecs. Co. Ltd. v. Unifi Sci.
`
`Batteries, LLC, IPR2013-00236, Paper 22 at 3 (PTAB Oct. 17, 2013).
`
`Lastly, in considering whether to join or consolidate proceedings, the Board
`
`must provide for a course which will “help ‘secure the just, speedy, and inexpensive
`
`resolution’ of these proceedings.” See 37 C.F.R. § 42.1(b); see also Amneal Pharm.
`
`LLC. v. Endo Pharm. Inc., IPR2014-01365, Paper 13 at 3 (PTAB Feb. 4, 2015);
`
`LaRose Indus., LLC v. Capriola Corp., IPR2013-00121, Paper 11 (June 28, 2013);
`
`6
`
`
`
`
`ABB, Inc. v. ROY-G-BIV Corp., IPR2013-00282, Paper 15 (Aug. 9, 2013) and
`
`Attorney Docket No. 39521-0020IP3
`Proceeding No. IPR2019-00139
`
`IPR2013-00286, Paper 14 (PTAB Aug. 9, 2013); Ariosa Diagnostics v. Isis
`
`Innovation, Ltd., IPR2013-00250, Paper 24 (PTAB Sept. 3, 2013); Cardiocom, LLC
`
`v. Robert Bosch Healthcare Sys., Inc., IPR2013-00469, Paper 21 (PTAB Jan. 28,
`
`2014).
`
`ARGUMENT
`
`A.
`
`Joinder Is Justified To Avoid Prejudice To Apple
`As discussed in the Petition at pages 6-24, Apple availed itself of IPR to gain
`
`expeditious review of the validity of IXI’s ’033 patent. By pursuing new claims in
`
`ex parte reexamination, IXI frustrated the purposes of Apple’s IPR and circumvented
`
`the Board’s amendment rules. Joinder is proper to rectify IXI’s tactics and allow
`
`Apple to complete the inter partes review challenge to IXI’s ’033 patent it previously
`
`sought.
`
`Here, the most efficient and just outcome is to allow joinder. As noted in the
`
`Petition, IXI obtained the Challenged Claims through gamesmanship—playing the
`
`odds of different proceedings before the USPTO in order to avoid the effect of this
`
`Board’s earlier determination of unpatentability and to avoid having its substitute
`
`claims challenged by Apple. If the Board finds this petition untimely and fails to
`
`join this IPR with the earlier IPR, Apple will be forced to litigate the validity of these
`
`claims in district court. This would reward IXI’s gamesmanship and result in an
`
`7
`
`
`
`
`outcome directly contrary to the purpose of IPR, which is to provide an alternative
`
`Attorney Docket No. 39521-0020IP3
`Proceeding No. IPR2019-00139
`
`to litigation without duplication of effort. Therefore, in the interest of expeditiously
`
`and efficiently resolving the dispute, the Board should exercise its discretion and join
`
`this IPR to the pending IPR of the ’033 patent. Gea Process Engr., Inc. Petr.,
`
`IPR2014-00051, 2014 WL 1253170, *6 (PTAB Mar. 10, 2014) (“our consideration
`
`of the amended claims in the reexamination certificate at this time advances our
`
`obligation to secure the ‘just, speedy, and inexpensive resolution’ of every
`
`proceeding”).
`
`B. Consolidation Is Appropriate Because of the Significant Overlap
`Between the Issues, Art, and Evidence in the Present Petition and the Prior
`IPR
`
`Consolidation with Apple’s previous IPR is appropriate because the issues
`
`raised in Apple’s current challenge significantly overlap with the issues raised in
`
`Apple’s previous IPR. As noted in Apple’s petition, the claims challenged in this
`
`petition share many limitations with the claims originally (and successfully)
`
`challenged in Apple’s original IPR. The Board has already found these limitations
`
`to be present in the prior art and has already examined the motivations of skilled
`
`artisan at the time of the invention—findings that have already been affirmed by the
`
`Federal Circuit. Apple cites the same prior art that was successfully used in Apple’s
`
`previous IPR to show that these limitations are still present in the prior art in the
`
`instant petition, thus (for these limitations) there is a complete overlap with Apple’s
`
`8
`
`
`
`
`previous IPR. These issues need not—and cannot—be relitigated should the present
`
`Attorney Docket No. 39521-0020IP3
`Proceeding No. IPR2019-00139
`
`petition be joined with Apple’s previous IPR. As a result, the issues to be addressed
`
`in the present IPR are narrower that what would normally be involved in an
`
`independent petition. In addition, the present petition involves the same parties as
`
`the previous IPR, and Apple has turned to the same expert that was involved in the
`
`previous proceeding.
`
`The only new issues to be addressed relate to the additional limitations of the
`
`claims emerging from re-examination. For new claim 65, these added limitations
`
`include limitations directed to: (1) router software, (2) “a speaker, a microphone, and
`
`a touchscreen;” (3) a “telephony application” used to place phone calls; (4) a
`
`“personal information manager application” which includes basic calendar, to-do
`
`list, emails, or contacts functionality; and (5) a “location application,” such as a basic
`
`mapping application, “for providing a current location” of the device. Marchand
`
`(the primary reference from IPR2015-01444) itself renders obvious several of these
`
`features because Marchand discloses a mobile phone and a skilled artisan would
`
`have found these features obvious to include in a mobile phone before IXI’s ’033
`
`patent. Indeed, the ’033 patent never contends that its invention relates to these
`
`features and only provides limited disclosure of them. And, for features not
`
`explicitly disclosed by Marchand, the Petition relies on only one new prior art
`
`9
`
`
`
`
`reference, Williams, to demonstrate how each of the new features lacking in
`
`Attorney Docket No. 39521-0020IP3
`Proceeding No. IPR2019-00139
`
`Marchand were well-known and obvious to include in Marchand’s mobile phone.
`
`As to the challenged dependent claims and claim 123, only two additional
`
`prior art references are needed to address them. Specifically, 802.11b is provided
`
`for disclosure of “software for 802.11 communications” (standard WiFi software)
`
`and Chen is cited for disclosure of “a GPRS baseband software component.” Thus,
`
`Apple has cited just three, additional prior art references to show how each of the
`
`added limitations in the challenged claims is present in the prior art and does not
`
`justify patentability.
`
`Further, Apple diligently filed the present petition challenging these additional
`
`limitations shortly after the Board regained jurisdiction over the previous IPR from
`
`the Federal Circuit. Thus, Apple’s request for joinder is similar to situations in which
`
`the Board has previously joined proceedings. For example, in Ariosa Diagnostics v.
`
`Isis Innovation, Ltd., the Board granted the petitioner’s motion for joinder (which
`
`patent owner opposed), finding that joinder was appropriate because the two
`
`proceedings “involve the same parties and the same patent” and because the petition
`
`to be joined “challenge[d] claims that are dependent on claims challenged in” the
`
`existing trial. Ariosa Diagnostics v. Isis Innovation, Ltd., IPR2013-00250, Paper 24
`
`at 2-3 (PTAB Aug. 12, 2013). Here, though the reexamination certificate should be
`
`considered a different “patent” for application of the time bar, the reexamination
`
`10
`
`
`
`
`certificate and the original patent challenged in the previous proceeding share the
`
`Attorney Docket No. 39521-0020IP3
`Proceeding No. IPR2019-00139
`
`same specification and involve many of the same limitations. In Ariosa, the Board
`
`also pointed to the fact that the joined proceedings “involve[d] much of the same
`
`prior art” and “[t]he only additional prior art cited in the instant proceeding was
`
`added to address the limitations of the dependent claims.” See id. The situation is
`
`similar here—Apple cites the same prior art for the many overlapping limitations
`
`from claims that were challenged in Apple’s original IPR, and the only new prior art
`
`is directed to limitations that have been added to the original subject matter. Lastly,
`
`in Ariosa, the Board found significant that the expert used in both proceedings was
`
`the same—which is also true here. See id. Thus, given these overlaps, joinder would
`
`be appropriate according to the Board’s previous decisions. See id.; see also, e.g.,
`
`Microsoft Corp. v. Proxyconn, Inc., IPR2013-00109, Paper 15, at 3-4 (PTAB Feb.
`
`25, 2013) (granting joinder because the “same patents and parties are involved in
`
`both proceedings,” there was “overlap in the cited prior art,” there was “no
`
`discernible prejudice to either party,” petitioner was “diligent and timely in filing the
`
`motion,” and there was no “undue delay”); ABB Inc. v. ROY-G-BIV Corp., IPR2013-
`
`00282, Paper 15, at 3 (PTAB Aug. 9, 2013) and IPR2013-00286, Paper 14, at 3
`
`(PTAB Aug. 9, 2013) (granting joinder because the cases “involve[] the same parties,
`
`the same patent, and much of the same prior art” and the “prior art references . . .
`
`substantially overlap”); LaRose Indus. v. Capriola Corp., IPR2013-00121, Paper 11,
`
`11
`
`
`
`
`at 23-24 (PTAB Jun. 28, 2013) (granting joinder in part because the cases
`
`Attorney Docket No. 39521-0020IP3
`Proceeding No. IPR2019-00139
`
`“involve[d] the same patent and parties, and there is some overlap in the asserted
`
`prior art . . . [and t]here also is no discernible prejudice to either party”); Cardiocom,
`
`LLC v. Robert Bosch Healthcare Sys., Inc., IPR2013-00469, Paper 21, at 13-15
`
`(PTAB Jan. 28, 2014) (granting joinder in part because the cases “involve[d] the
`
`same patent, parties, and prior art[, and t]here also is no discernible prejudice to
`
`either party”).
`
`C. Consolidation Will Have Little Impact on the Schedule for the Prior
`IPR Because the Board Has Already Issued its Final Written Decision, and
`Any Concerns Could Be Addressed By An Abbreviated Briefing Schedule
`In this factor, the Board considers whether joinder would impact the Board’s
`
`ability to issue a final written decision within the statutory time period. In this case,
`
`this is not a concern, as the Board has already met the statutory deadline by issuing
`
`a final written decision finding all claims previously challenged to be unpatentable.
`
`That decision has been affirmed by the Federal Circuit, and the Board regained
`
`jurisdiction over the previous IPR when the Federal Circuit issued its mandate on
`
`October 17. There are no deadlines left to meet. Without any deadlines to meet, the
`
`previous IPR may continue for the time period necessary to resolve the new issues
`
`raised in the present IPR petition.
`
`As for timing of the briefing, any concerns about delay could be alleviated if
`
`the Board adopts an abbreviated briefing schedule—similarly to how the Board
`
`12
`
`
`
`
`addresses remands from the Federal Circuit. In such situations, the PTO has set forth
`
`Attorney Docket No. 39521-0020IP3
`Proceeding No. IPR2019-00139
`
`guidance suggesting that the Board “issue decisions on remanded cases within six
`
`months of the Board’s receipt of the Federal Circuit’s mandate.” PTAB Standard
`
`Operating Procedure 9, available at https://goo.gl/1VypwC. Given the overlap in
`
`the present petition and Apple’s previous challenge, the issues to be decided are
`
`narrow—similar to what might happen if the Federal Circuit remands to the Board,
`
`adopting a similar procedure here may be appropriate.
`
`CONCLUSION
`
`For the foregoing reasons, Apple requests that the Board consolidate this
`
`present petition for IPR with pending Case No. IPR2015-01444.
`
`Respectfully submitted,
`
`
`
`
`
`
`/W. Karl Renner/
`W. Karl Renner, Reg. No. 41,265
`Jeremy J. Monaldo, Reg. No. 58,680
`Fish & Richardson P.C.
`3200 RBC Plaza, 60 South Sixth Street
`Minneapolis, MN 55402
`T: 202-783-5070
`F: 877-769-7945
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Dated: November 8, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`13
`
`
`
`
`
`Dated: November 8, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Attorney Docket No. 39521-0020IP3
`Proceeding No. IPR2019-00139
`
`
`
`
`
`
`
`/Jeremy J. Monaldo/
`W. Karl Renner, Reg. No. 41,265
`Jeremy J. Monaldo, Reg. No. 58,680
`Fish & Richardson P.C.
`3200 RBC Plaza, 60 South Sixth Street
`Minneapolis, MN 55402
`T: 202-783-5070
`F: 877-769-7945
`
`Attorneys for Petitioner
`
`14
`
`
`
`Attorney Docket No. 39521-0020IP3
`Proceeding No. IPR2019-00139
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(4)(i) et seq. and 42.105(b), the undersigned
`
`certifies that on November 8, 2018, a complete and entire copy of this Petitioner’s
`
`Motion for Joinder and/or Consolidation was provided via Federal Express, to the
`
`Patent Owner by serving the correspondence address of record as follows:
`
`Brooks Kushman P.C.
`1000 Town Center, 22nd Floor
`SOUTHFIELD MI 48075
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/Diana Bradley/
`
`Diana Bradley
`Fish & Richardson P.C.
`60 South Sixth Street, Suite 3200
`Minneapolis, MN 55402
`(858) 678-5667
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`